Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1868.7 (Glytoucan)

Id:4c710b1e-b772-5142-b682-aca6b3bb7cc4

Glytoucan:G57695ZB

Results found

Linked to

	Label	Description
	1868.7 has glycosequence GLYGEN.GLYCOSEQUENCE:G56036XY-GLYCOSEQ00039331 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.7 has canonical residue n-glycan b-d-glcpnac 9 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.7 has glycosequence GLYGEN.GLYCOSEQUENCE:G75472JW-GLYCOSEQ00147236 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.7 has canonical residue n-glycan core b-d-glcpnac b Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.7 has glycosequence GLYGEN.GLYCOSEQUENCE:G78015OA-GLYCOSEQ00193646 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.7 has glycosequence GLYGEN.GLYCOSEQUENCE:G12768AE-GLYCOSEQ00197181 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.7 has glycosequence GLYGEN.GLYCOSEQUENCE:G28593TO-GLYCOSEQ00042018 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.7 has glycosequence GLYGEN.GLYCOSEQUENCE:G07326IT-GLYCOSEQ00155534 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.7 has glycosequence GLYGEN.GLYCOSEQUENCE:G78555BT-GLYCOSEQ00097005 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1868.7 has glycosequence GLYGEN.GLYCOSEQUENCE:G04508HC-GLYCOSEQ00063879 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.7 has glycosequence GLYGEN.GLYCOSEQUENCE:G56036XY-GLYCOSEQ00039331 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.7 has canonical residue n-glycan b-d-glcpnac 9

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.7 has glycosequence GLYGEN.GLYCOSEQUENCE:G75472JW-GLYCOSEQ00147236 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.7 has canonical residue n-glycan core b-d-glcpnac b

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.7 has glycosequence GLYGEN.GLYCOSEQUENCE:G78015OA-GLYCOSEQ00193646 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.7 has glycosequence GLYGEN.GLYCOSEQUENCE:G12768AE-GLYCOSEQ00197181 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.7 has glycosequence GLYGEN.GLYCOSEQUENCE:G28593TO-GLYCOSEQ00042018 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.7 has glycosequence GLYGEN.GLYCOSEQUENCE:G07326IT-GLYCOSEQ00155534 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.7 has glycosequence GLYGEN.GLYCOSEQUENCE:G78555BT-GLYCOSEQ00097005 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1868.7 has glycosequence GLYGEN.GLYCOSEQUENCE:G04508HC-GLYCOSEQ00063879 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.